Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA LUPIN AUROBINDO PHARMA/
LUPIN
 
P/E (TTM) x 13.8 -14.6 - View Chart
P/BV x 1.4 2.6 52.0% View Chart
Dividend Yield % 1.6 0.6 272.3%  

Financials

 AUROBINDO PHARMA   LUPIN
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
LUPIN
Mar-22
AUROBINDO PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs1,0641,268 83.9%   
Low Rs584679 86.1%   
Sales per share (Unadj.) Rs400.3361.0 110.9%  
Earnings per share (Unadj.) Rs45.7-33.2 -137.6%  
Cash flow per share (Unadj.) Rs64.93.3 1,980.8%  
Dividends per share (Unadj.) Rs9.004.00 225.0%  
Avg Dividend yield %1.10.4 265.7%  
Book value per share (Unadj.) Rs419.4263.9 159.0%  
Shares outstanding (eoy) m585.94454.48 128.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.12.7 76.4%   
Avg P/E ratio x18.0-29.3 -61.5%  
P/CF ratio (eoy) x12.7296.8 4.3%  
Price / Book Value ratio x2.03.7 53.3%  
Dividend payout %19.7-12.0 -163.5%   
Avg Mkt Cap Rs m482,799442,238 109.2%   
No. of employees `000NANA-   
Total wages/salary Rs m34,50929,893 115.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,555164,055 143.0%  
Other income Rs m3,2262,137 151.0%   
Total revenues Rs m237,781166,192 143.1%   
Gross profit Rs m42,5662,152 1,977.6%  
Depreciation Rs m11,26516,587 67.9%   
Interest Rs m4861,428 34.1%   
Profit before tax Rs m34,040-13,726 -248.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2561,372 529.1%   
Profit after tax Rs m26,784-15,097 -177.4%  
Gross profit margin %18.11.3 1,383.2%  
Effective tax rate %21.3-10.0 -213.3%   
Net profit margin %11.4-9.2 -124.1%  
BALANCE SHEET DATA
Current assets Rs m181,227124,577 145.5%   
Current liabilities Rs m81,56082,764 98.5%   
Net working cap to sales %42.525.5 166.7%  
Current ratio x2.21.5 147.6%  
Inventory Days Days2533 75.7%  
Debtors Days Days6295 65.8%  
Net fixed assets Rs m155,10491,938 168.7%   
Share capital Rs m586909 64.5%   
"Free" reserves Rs m245,174119,006 206.0%   
Net worth Rs m245,760119,915 204.9%   
Long term debt Rs m2,4921,419 175.7%   
Total assets Rs m336,331216,515 155.3%  
Interest coverage x71.0-8.6 -824.1%   
Debt to equity ratio x00 85.7%  
Sales to assets ratio x0.70.8 92.0%   
Return on assets %8.1-6.3 -128.4%  
Return on equity %10.9-12.6 -86.6%  
Return on capital %13.9-10.1 -137.2%  
Exports to sales %31.10-   
Imports to sales %11.90-   
Exports (fob) Rs m72,862NA-   
Imports (cif) Rs m27,965NA-   
Fx inflow Rs m77,24553,594 144.1%   
Fx outflow Rs m31,52438,143 82.6%   
Net fx Rs m45,72115,451 295.9%   
CASH FLOW
From Operations Rs m50,1653,673 1,365.7%  
From Investments Rs m-32,11612,922 -248.5%  
From Financial Activity Rs m-29,693-15,723 188.8%  
Net Cashflow Rs m-11,674872 -1,338.5%  

Share Holding

Indian Promoters % 48.8 46.8 104.1%  
Foreign collaborators % 3.1 0.3 1,096.4%  
Indian inst/Mut Fund % 38.0 41.5 91.7%  
FIIs % 20.7 14.3 145.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 52.9 91.1%  
Shareholders   359,684 382,828 94.0%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    ZYDUS LIFESCIENCES    PIRAMAL ENTERPRISES    



Today's Market

Sensex Tanks 652 Points, Nifty Ends Below 17,800; IndusInd Bank & Bajaj Finserv Top Losers(Closing)

After opening the day on a flat note, Indian share markets turned volatile during the afternoon session and fell hard as selling was seen in banking and auto stocks.